Datasheet

Page 2/9
Safetydatasheet
accordingto1907 /2006/EC ,A rticle 31
Printing date 24.08.2017 Revision: 24.08.2017Version number 4
Trade name:ergo5300
(Contd. of page 1)
45.2.18
-
L abellingofpackages where the contents donotexceed 125ml
-
H azard pictograms

GHS07
-
Signalword
Warning
-
H azard-determiningcomponents oflabelling:
ethyl 2-cyanoacrylate
-
H azard statements
Void
-
2.3O therhazards
-
Resu lts ofP B T and vP vB assessment
-
P B T:
Not applicable.
-
vP vB :
Not applicable.
S E C TIO N 3:C omposition/information on ingredients
-
D escription:
Adhesive
-
D angerou s components:
CAS: 7085-85-0
EINECS: 230-391-5
Reg.nr.: 01-2119527766-29-xxxx
ethyl 2-cyanoacrylate
Skin Irrit. 2, H315; Eye Irrit. 2, H319; STOT SE 3, H335
50-<100%
CAS: 123-31-9
EINECS: 204-617-8
1,4-dihydroxybenzene
Muta. 2, H341; Carc. 2, H351; Eye Dam. 1, H318; Aquatic
Acute 1, H400; Acute Tox. 4, H302; Skin Sens. 1, H317
0.025-<0.1%
-
A dditionalinformation:
For the wording of the listed hazard phrases refer to section 16.
S E C TIO N 4:Firstaid measu res
-
4.1 D escription of firstaid measu res
-
Generalinformation:
Immediately remove any clothing soiled by the product.
-
A fterinhalation:
Supply fresh air. If required, provide artificial respiration. Keep patient warm. Consult doctor if symptoms
persist.
In case of unconsciousness place patient stably in side position for transportation.
-
A fterskin contact:
After contact with skin, wash immediately with plenty of soap and water.
If skin irritation continues, consult a doctor.
-
A ftereye contact:
In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
Rinse cautiously with water for several minutes.
Remove contact lenses, if present and easy to do. Continue rinsing.
-
A fterswallowing:
Rinse out mouth and then drink plenty of water.
If swallowed, do not induce vomiting: seek medical advice immediately and show this container or label.
-
4.2 M ostimportantsymptoms and effects,bothacu te and delayed
No further relevant information available.
-
4.3Indication ofanyimmediate medicalattention and specialtreatmentneeded
No further relevant information available.
GBGEN
(Contd. on page 3)